Difference in serum cytokines between metastatic colorectal cancer patients with mutant and wild type RAS in response to targeted treatment with monoclonal antibodies

Cytokines and chemokines play dual – pro- and antioncogenic – roles in tumor progression. Targeted medications of monoclonal antibodies, anti-VEGF (bevacizumab) and anti-EGFR (cetuximab, panitumumab), are widely used in treatment of metastatic colorectal cancer (mCRC) and are prescribed in dependenc...

Celý popis

Podrobná bibliografie

Hlavní autoři:	E. Yu. Zlatnik, A. B. Sagakyants, L. Yu. Vladimirova, A. V. Tishina
Médium:	Artigo
Jazyk:	Russo
Vydáno:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2024-07-01
Edice:	Медицинская иммунология
Témata:	cytokines chemokines multiplex analysis colorectal cancer kras mutation monoclonal antibodies for treatment
On-line přístup:	https://www.mimmun.ru/mimmun/article/view/3057
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!